Funding Directory

The British Heart Foundation (BHF) provides funding for the appointment of professors to universities which can show a strong commitment to cardiovascular research. Professors are expected to bring research leadership at an internationally competitive level and a commitment to training future cardiovascular scientists as well as the ability to enhance the overall cardiovascular research strategy of the university. 

For more information or to apply for the funding opportunity, visit the BHF website today!

Award to fund travel and subsistence costs for current PhD students and early career researchers to attend conferences, training, workshops and placements that are within the remit of the STFC Cancer Diagnosis Network+. 

For more information or to apply for the funding opportunity, visit the UKRI website today!

The British Heart Foundation (BHF) provides grants to assist with the cost of providing essential infrastructure to support cardiovascular research in any academic institution in the UK. 

Funding could be used, for example, to help refurbish a building or purchase major items of equipment to support the activities of several cardiovascular researchers which could not ordinarily be requested on Project or Programme Grants. 

For more information or to apply for the funding opportunity, visit the BHF website today!

You have the opportunity to seek funding for initiating new endeavors or sustaining ongoing activities, or to aid your organization in responding and adjusting to emerging challenges. Funding is available for projects that aim to achieve at least one of the following objectives: fostering community connections and robust relationships, enhancing community-relevant locations, aiding individuals in realizing their full potential by providing early-stage support, and assisting people, communities, and organizations grappling with increased demands and challenges due to the cost-of-living crisis.  

For more information or to apply for the funding opportunity, visit the The National Lottery  website today!

Funding and venture creation support aimed at researchers funded by Cancer Research UK seeking to develop start-up enterprises to commercialise therapeutics, diagnostics and medical devices for cancer. The Cancer Research Horizons Seed Fund is a £15 million investment from Cancer Research UK that provides early-stage capital investment for start-up ventures arising from research funded by Cancer Research in the UK and internationally, including the Cancer Grand Challenges programme. 

For more information or to apply for the funding opportunity, visit the Cancer Research Horizons website today!

The Small Grants program supports researchers in developing projects focused on advancing our understanding of neuroblastoma development. This initial funding can serve as a springboard for larger grant applications aimed at pioneering more effective treatment approaches.  

For more information or to apply for the funding opportunity, visit the neuroblastoma website today! 
 

Funding is available to assist with small meetings or events to sustain and develop the UK cardiovascular research community. 

For more information or to apply for the funding opportunity, visit the BHF website today!

The aim of the New Horizons Grants scheme to provide funding to encourage researchers working outside traditional cardiovascular biology to become involved in cardiovascular research and thus add new expertise to the field. Projects may involve basic or applied clinical research but should be relevant to the cardiovascular system. Examples of such collaborations might include co-operative enterprises between biologists and engineers, physicists or mathematicians. 

For more information or to apply for the funding opportunity, visit the BHF website today!

Investment funding to support early-stage spin-out companies developing innovative medical products and technologies with the potential to impact on patients' lives. LifeArc Ventures is designed to bridge the gap between academic innovations and the early stages of commercialisation/venture funding. It provides early-stage investment for innovative therapeutics, medical devices, health-tech and diagnostics, with a focus on Seed and 'Series A' investment rounds, with significant follow-on investment reserved for successful portfolio companies. 

For more information or to apply for the funding opportunity, visit the LifeArc website today!

The aim of the Pancreatic Cancer UK Collaboration Catalyst Awards is to encourage clinical and non-clinical researchers in the UK to establish and/or develop collaborations and networks to address a research challenge or question within the field of pancreatic cancer. Awards are intended to fund the following activities: 

• Participation in research visits, including secondments to collaborating research groups.
• Hosting researcher workshops and/or discussion-style type meetings to build collaborations and networks. 

For more information or to apply for the funding opportunity, visit the Pancreatic Cancer website today!

Research funding to improve the health of overweight and obese people. Research should be evidence-based approaches, and effective interventions.   

For more information or to apply for the funding opportunity, visit the UKRI website today!

Funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions. You can apply for academically led translational projects that aim to either: improve prevention, diagnosis, prognosis or treatment of significant health needs. Develop research tools that increase the efficiency of developing interventions. 

For more information or to apply for the funding opportunity, visit the UKRI  website today!

The Efficacy and Mechanism Evaluation (EME) Programme funds bold studies that aim to significantly advance health promotion, disease treatment, and the improvement of rehabilitation or long-term care. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

The MRC-NIHR Efficacy and Mechanism Evaluation (EME) Programme is seeking applications for efficacy trials focused on improving women's health and wellbeing. Trials may address conditions unique to women or those that affect both genders but impact women differently or more severely. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

The CRUK Prevention and Population Research Awards provide support for focused research proposals centred on key questions in prevention and population research. 

The thematic focus of the programme covers cancer aetiology, as well as cancer prevention, epidemiology, behavioural research, statistics and methodology, and clinical trials. 

For more information or to apply for the funding opportunity, visit the CRUK website today!

The Biology to Prevention Awards aim to drive translational research that enhances biological and mechanistic understanding of cancer's causes, development, and risk, ultimately leading to precision prevention interventions. Applicants must clearly justify how their work will impact cancer risk reduction or incidence, aligning with the Prevention Research Strategy. This connection should be thoroughly considered. 

For more information or to apply for the funding opportunity, visit the CRUK website today!

This funding opportunity supports the progression of basic research towards application and impact in one of three key challenges: improving population health and prevention, transforming prediction and early diagnosis, and accelerating the development of new interventions. UKRI seek applications that advance engineering and physical sciences research to address unmet healthcare needs within the proposal’s timeframe. Projects must be co-developed and co-delivered with clinical or healthcare professionals, industry partners, and public or patient contributors to maximize impact and facilitate translation. 

For more information or to apply for the funding opportunity, visit the UKRI website today!

The CRUK Early Detection Project Awards fund exceptional science that will drive a transformational change in how and when early cancers and pre-cancerous states are detected. The awards will support a wide range of scientific research from basic to translational/clinical, and incorporate scientists from diverse fields including molecular biologists, clinicians, engineers, physicists, chemists and mathematicians. The ultimate goal is to improve how and when cancer is detected. Early detection and diagnosis (ED&D) research seeks to detect and diagnose consequential precancerous changes and cancer at the earliest possible point at which an intervention might be made, reducing the burden of late-stage disease. 

For more information or to apply for the funding opportunity, visit the CRUK website today!

What are the most effective interventions that organisations can adopt to improve the physical and mental health of the UK workforce? Workplace ill-health costs the UK economy billions annually, with common issues like minor illnesses, musculoskeletal conditions, and poor mental health leading to lost working days. Successful interventions require committed leadership and a preventive, proactive approach. The PHR Programme seeks research evaluating organizational-wide interventions that address health inequalities and broader health determinants, enhancing the evidence base for effective health interventions across diverse workplace contexts.

For more information or to apply for the funding opportunity, visit the NIHR website today!

This study aims to assess the feasibility of conducting a randomised clinical trial comparing surgery and conservative management for patients with tennis elbow symptoms persisting for over six months. Eligible participants are those who have experienced symptoms beyond six months. The intervention involves surgery, with the specific type defined by applicants, while the comparator is conservative management such as physiotherapy, allowing for subsequent surgery if necessary. Recruitment efforts should focus on underserved regions with a high incidence of the condition. The primary outcome is to determine the practicality of conducting a full RCT, while secondary outcomes include Patient Rated Tennis Elbow Evaluation (PRTEE) scores, quality of life measures, and work capability assessments. Conducted in secondary care settings, the feasibility study will explore factors like acceptance of randomization by patients and healthcare professionals and potential recruitment challenges. The decision to proceed with a comprehensive RCT will be based on the findings from this preliminary study. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

This PHR call 24/61 Healthy Homes: Overcrowding seeks to assess which interventions impact overcrowding in housing in the UK. Housing is an important determinant of health. There is extensive evidence to show that secure, affordable and decent housing protects individual health and supports communities to be healthy and resilient. As well as the physical and mental health benefits for individuals, families and communities, healthy homes have the potential to bring wider societal benefits. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

The PHR programme is predominantly interested in the evaluation of interventions operating at a population level rather than at an individual level, and that address health inequalities and the wider determinants of health. It is recognised that interventions are likely to impact different (sub)populations in different ways and researchers are encouraged to explore such inequalities of impact in their study design. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

NICE is updating guidance on 'Weight management: lifestyle services for overweight or obese children and young people' (PH47). The Public Health Research (PHR) Programme is particularly interested in the effectiveness and cost-effectiveness of long-term behavioral interventions for weight management in children and young people. Addressing childhood obesity is crucial, as it often leads to adult obesity and associated health issues like anxiety, depression, and social stigma. Obesity rates are highest in deprived areas, exacerbating health inequalities.

The PHR Programme seeks research evaluating population-level interventions in non-NHS settings, focusing on long-term support (over six months) for weight management. Research should consider different subpopulations, including ethnic minorities and vulnerable groups, and measure the effectiveness, cost-effectiveness, and health impact of interventions over 5-10 years. Researchers should involve service users in study design, justify their methodological approach, and include economic and policy considerations. Detailed application guidance and deadlines can be found on the PHR Programme's main funding opportunities page.

For more information or to apply for the funding opportunity, visit the NIHR website today!

The EIC Accelerator supports SMEs and start-ups in scaling high-impact innovations that can create new markets or disrupt existing ones. It provides funding between EUR 0.5 and EUR 17.5 million, along with Business Acceleration Services. Focusing on 'deep tech' innovations based on scientific discoveries or technological breakthroughs, the program targets projects requiring significant funding over long periods ('patient capital'). EIC Accelerator funding helps attract necessary investments for faster scaling. Eligible projects must have technology tested and validated at least at Technology Readiness Level 5. The program aims to catalyse additional investment for scaling innovations. 

For more information or to apply for the funding opportunity, visit the European Commission   website today! 

The Public Health Research (PHR) Programme supports research aimed at improving public health and reducing health inequalities through non-NHS interventions.

The Rapid Funding Scheme (RFS) provides researchers with funding for rapid baseline data collection and feasibility work preceding intervention implementation. Offering an accelerated route to funding for small-scale, time-sensitive proposals, subject to scientific scrutiny.  

NIHR  

The Fund provides grants and financial support to academic researchers advancing new treatments and diagnostics for rare diseases. This funding enables research projects to stay in academia longer and progress further along the development pathway, making them more attractive to follow-on investors. 

For more information or to apply for the funding opportunity, visit the LifeArc  website today!

This grant is intended for basic science research projects exceeding £350,000 in cost or spanning more than three years. It also supports funding for studies utilizing datasets only, population and patient-based cohort studies (epidemiology), or experimental medicine studies that surpass the £350,000 threshold or extend beyond three years. 

For more information or to apply for the funding opportunity, visit the BHF website today!

Funding for research studies that address the James Lind Alliance (JLA) Priority Setting Partnerships' (PSPs) research priorities.

The JLA PSPs bring together patients, carers, and clinicians to identify key research priorities in health and care. Their goal is to ensure health research addresses the most important issues for those who use it. We are offering ongoing research funding through four of our programs, with funding rounds reopening shortly after each round closes, allowing applications at any time.

For more information or to apply for the funding opportunity, visit the NIHR website today!

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for investigator-initiated clinical trials related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences. Such trials must have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer. With such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. 

For more information or to apply for the funding opportunity, visit the NIH website today!

This funding opportunity invites applications from professionals in brain tumour diagnosis, follow-up, rehabilitation, supportive, and end-of-life care, from various health and care backgrounds. NIHR particularly encourage applicants from under-represented fields, including allied health professionals (AHPs), nurses, and mental health specialists involved in brain tumour care, support, and rehabilitation, as lead, joint-lead, or co-applicants. Studies may focus on any type or grade of primary brain tumours in adults or children, including benign, cancerous, metastasised, recurrent, or relapsed tumours, and those in remission or living with brain cancer. 

For more information or to apply for the funding opportunity, visit the NIHR website today! 
 

HTA call 24/76 Studies Seeking to Improve the Health and Wellbeing of Women will fund applications for studies that aim to improve the health and wellbeing of women. This could include, but is not limited to: 

• Trials investigating conditions that only affect women.
• Conditions that affect both men and women, but which affect women either disproportionately or in a different way. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

The Neurosciences and Mental Health Board aims to deepen understanding of the nervous system in health and disease, and improve treatments for brain disorders. They support research on the nervous system’s interaction with the body, and how life events impact long-term mental and neurological health. Priority areas include neurodegeneration, mental health, addictions, learning disorders, cognitive and sensory neuroscience, and neurobiology. This funding supports coordinated projects addressing related questions across a broad research area. 

For more information or to apply for the funding opportunity, visit the UKRI  website today!

Funding for new investigators to grow into independent researchers, focusing on research that advances understanding in molecular and cellular medicine.

The Molecular and Cellular Medicine Board (MCMB) supports studies on biological mechanisms and technologies related to human health, including areas such as cell biology, structural biology, genetics, stem cell biology, molecular haematology, and cancer. Prioritising research on molecular structures, cellular environments, responses to disease or toxins, and the development of tools like nanotechnology, synthetic biology, and medical bioinformatics. Cancer research, from discovery to early translation, is a key focus. 

For more information or to apply for the funding opportunity, visit the UKRI website today! 
 

Funding for new investigators ready to become independent researchers, with proposals that advance understanding in infections and immunity. The Infections and Immunity Board  supports research that deepens our knowledge of human infectious diseases and the immune system’s role in inflammation, immune-mediated diseases, and cancer. This includes studying human pathogens, immune system disorders, and conditions caused by immune dysregulation.

They aim to fund a diverse portfolio, addressing key issues and emerging opportunities relevant to both the UK and globally. Areas of interest include pathogens, immunology, inflammation, antimicrobial resistance, chronic infections, vaccines, diagnostics, and therapeutics. 

For more information or to apply for the funding opportunity, visit the NIHR website today! 
 

The Grace Kelly Childhood Cancer Trust (GKCCT) is a research charity that raises awareness of childhood cancers and provides funding to support research into rare, aggressive and difficult to treat childhood cancers, including rhabdoid tumours. Its priority for research is on projects with clear translatable outcomes that are most likely to lead to an improvement in treatment in the relatively near future, with a focus on early diagnosis and awareness; patients with poor outcomes from diagnosis; research associated with larger clinical trials (eg biomarker studies); and rare tumour types. 

For more information or to apply for the funding opportunity, visit the GKCCT website today!

Funding for universities and providers of care services for high-quality social care research that generates evidence to improve, expand and strengthen the way adult social care in the UK is delivered for users of care services, carers and the public. Research is required that generates evidence to improve, expand and strengthen the way social care is provided for users of care services, carers, the social care workforce and the public across the UK (England, Wales, Scotland and Northern Ireland). The programme will fund primary, secondary and evidence synthesis research including qualitative, quantitative and mixed methods designs. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

Blood Cancer UK provide the Innovative Pilot Grant scheme to support researchers with novel research ideas in areas related to blood cancer, helping them develop pilot data needed to secure further investment from other Blood Cancer UK grant schemes, medical research funders or industry. Research projects should aim to develop pilot data in novel areas of research with the potential to impact the understanding, prevention, diagnosis, treatment or management of blood cancer. 

For more information or to apply for the funding opportunity, visit the Blood Cancer UK website today!

Funding for research projects that will drive tangible change in health policy and practice in the near future through practical, impact-driven research. Support ranges from feasibility studies with impact evaluation and stakeholder engagement, late-stage intervention development and testing (including global health trials from phase 2b onwards), implementation and scale-up research, health economics within broader health intervention projects, studies on the impact of policy changes on health with a multisectoral approach, and environmental, cultural, and social approaches in health-focused projects, as well as applied modelling research. 

For more information or to apply for the funding opportunity, visit the UKRI website today!

Support for research that advances understanding of the biological, psychological and/or social mechanisms in which heat can affect anxiety, depression or psychosis. Projects supported by this award must also illustrate the translational implications of the research, either now or in the future. Successful applications will identify relevant climate-resilient and/or mental health interventions with a realistic potential for real-world application. 

For more information or to apply for the funding opportunity, visit the Wellcome website today!

HTA offers insights into the effectiveness and cost-effectiveness of care as delivered in typical clinical settings, accounting for the diverse range of patients eligible for the interventions being studied. Research should focus on patients with a history of essential hypertension and postural hypotension with symptoms like light-headedness or falls. Studies should consider the diverse clinical features and underlying mechanisms, particularly in underserved populations.

The intervention should prioritize hypertension control, while the comparator focuses on managing postural hypotension symptoms. Key outcomes include changes in symptoms and blood pressure control, along with hospital admissions, quality of life, and health economics. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

This study aims to evaluate the clinical and cost effectiveness of an alternate day caplacizumab regimen compared to daily dosing in patients with immune thrombotic thrombocytopenic purpura (iTTP) who have achieved normal platelet counts. The intervention group will receive caplacizumab every other day, while the control group will continue with daily dosing, both in addition to standard care. Key outcomes include TTP relapse or exacerbation, bleeding events, and maintenance of normal platelet count. Secondary outcomes include adverse events, cost-effectiveness, and quality of life. Core Outcomes should be included unless otherwise justified, with data reported by sex and other relevant demographics. The study will be conducted in secondary care settings, featuring an internal pilot phase to assess recruitment and adherence, with clear stop/go criteria guiding progression to the full trial. Follow-up duration will be defined and justified by applicants. 

For more information or to apply for the funding opportunity, visit the NIHR  website today!

This feasibility study will evaluate whether a randomized trial comparing hysteroscopy with polyp removal (outpatient and inpatient) to conservative management is viable for treating premenopausal women with abnormal uterine bleeding diagnosed with endometrial polyps. The intervention group will receive hysteroscopy and polyp removal, while the control group will get conservative medical management, defined and justified by applicants. Key objectives include assessing equipoise from patients and clinicians, recruitment feasibility, and the acceptability of randomization. Important outcomes to determine include health-related quality of life, potential benefits and harms, and trial delivery feasibility. Applicants should report data disaggregated by sex, gender, and other demographics. The study will be conducted in any suitable setting and include a randomized pilot phase to test recruitment, adherence, and other trial processes. Qualitative research with patients and clinicians will explore their decisions and the role of hysteroscopy versus conservative management. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

MRC CoREs should be outward facing and harness the best talent in the UK to provide a stimulating environment in which to train the next generation of researchers and technologists. MRC CoREs are expected to adopt and maintain the highest standards in the way research is conducted and openly communicated and develop and nurture career paths and a training environment which supports a positive research culture. As such, applications must emphasise the following three key principles that underpin a positive research culture: 

• Research is conducted with integrity, centred on reproducibility, responsible innovation, collaboration, interdisciplinarity and multidisciplinarity.
• Research is communicated to maximise impact, built on transparency and openness, and partnership with the public.
• Career paths and training environment, are provided to recognise a diversity of talents, skills and outputs, and embrace team science as the way of working. 

For more information or to apply for the funding opportunity, visit the UKRI website today!

The BRACE Equipment Grants support researchers at universities in South West England and South Wales undertaking research into Alzheimer's and other forms of dementia, including Lewy body dementia, frontotemporal dementia, and vascular dementia. Applications from areas related to dementia are also welcomed, including Traumatic Brain Injury, mild cognitive impairment (MCI) and young-onset dementia. Research of dementia associated with other neurological disorders, such as dementia in Parkinson’s and dementia related to Huntington’s disease, is also eligible, providing the primary research focus is on the dementia-related aspects of the disease. All researchers must intend to publish the results of their studies. 

For more information or to apply for the funding opportunity, visit the BRACE website today!

Blood Cancer UK offers Research Project Grants to provide support for clearly defined research proposals that aim to address key questions in the field of blood cancer in line with their strategic aims. Their research strategy 2023-2028 focuses on bringing forward the day when no one dies of blood cancer or its treatments. For this annual call applications are invited for open response-mode research projects addressing novel questions that could help reach that goal. There are no prioritised research themes for this round. 

For more information or to apply for the funding opportunity, visit the Blood Cancer UK website today!

Funding for early career and experienced researchers to develop early, novel and outside-the-box ideas and collaborations to advance the early detection and diagnosis of cancer. The CRUK Early Detection and Diagnosis Primer Awards provide seed funding to develop new relationships, ideas and lines of research, and the generation of pilot data. The aim is to encourage scientists at all career stages to engage with the early detection of cancer field and to drive innovation in how and when cancer is detected. The awards will support new and exploratory research ideas and/or pilot studies of high scientific risk and potential reward. It will support the development of new partnerships and exploration of highly novel concepts, involving researchers from any research area, including from non-traditional cancer fields. 

For more information or to apply for the funding opportunity, visit the CRUK website today!

The Prevention and Population Research Programme Award is intended to support UK researchers undertaking long-term, broad and multidisciplinary projects with transformative potential in prevention and population research. It is intended to allow applicants the freedom to pursue novel research avenues. 

For more information or to apply for the funding opportunity, visit the CRUK website today!

Funding over five years to support long-term, integrated research programmes with potential to transform the early detection and diagnosis of early cancers and pre-cancerous states.  

For more information or to apply for the funding opportunity, visit the CRUK website today!

The DEBRA UK Project Grants provide funding over two to three years to support UK and international researchers conducting projects within the scope of the DEBRA UK research priorities. Projects must have clear aims and objectives to advance scientific understanding of EB and therapeutic interventions and be feasible and achievable in the stated time period. Applications will be judged on relevance to EB, scientific merit and novelty. 

For more information or to apply for the funding opportunity, visit the DEBRA UK website today!

The scheme provides long term support for broad, multidisciplinary projects in basic and translational research associated with cancer from established individuals. The CRUK research funding programme awards a wide range of fellowships and grants to support researchers, across all career stages, conducting clinical, pre-clinical, discovery and translational research to advance the detection, diagnosis, treatment, and potential cure, of all forms of cancer. 

For more information or to apply for the funding opportunity, visit the CRUK website today!

The Institute's postdoctoral career development fellowships provide an opportunity for exceptional postdoctoral clinicians to consolidate their research experience. Postdoctoral clinicians can apply for funding to spend one year full-time or two years part-time working in a Crick research group, on a project agreed between the fellow and the Crick group leader. 

The aim of the scheme is to: 

• Foster long-term clinical links and collaborations.
• Provide clinicians with a postdoctoral extension of their research experience, and with scientific networking, training and career development opportunities at the Crick.
• Provide a platform from which fellows may apply for external funding such as clinician scientist fellowships, to be held at the Crick or elsewhere. 

For more information or to apply for the funding opportunity, visit the Francis Crick Institute website today!

This Funding Opportunity Announcement encourages applications that investigate the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem globally. Because of the high incidence and frequent tumour recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression and malignancy of bladder cancer. Furthermore, understanding of the biological processes of the normal bladder at the molecular, cell and organ levels is limited. 

Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid understanding of bladder cancer biology and contribute to the future development of new interventions. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

This Funding Opportunity Announcement (FOA) supports discrete, well-defined projects in any area of cancer research using the NIH R03 small grant mechanism. The NIH R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following: 

• Pilot or feasibility studies.
• Secondary analysis of existing data.
• Small, self-contained research projects.
• Development of research methodology.
• Development of new research technology.

For more information or to apply for the funding opportunity, visit the NIH website today!

This Notice of Funding Opportunity (NOFO) invites mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including one's response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental and systemic factors. Expectancy effects are the cognitive, behavioural and biological outcomes caused by expectancies. Expectancy effects can be generated by expectancies held by patients, clinicians, family members, caregivers and/or dyadic/social networks.

For more information or to apply for the funding opportunity, visit the NIH website today!

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). 

The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs. 

For more information or to apply for the funding opportunity, visit the NIH website today!